{
  "cik": 1764013,
  "cik_padded": "0001764013",
  "entityName": "Immunovant, Inc.",
  "fiscal_years": [
    {
      "accn": "0001764013-26-000064",
      "filed": "2026-05-20",
      "fiscal_year": 2026,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 8000.0,
        "cash": 902110000.0,
        "eps_diluted": -2.77,
        "free_cash_flow": -407318000.0,
        "net_income": -505606000.0,
        "operating_cash_flow": -407310000.0,
        "stockholders_equity": 852592000.0,
        "total_assets": 957014000.0,
        "total_liabilities": 104422000.0
      },
      "period_end": "2026-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.12247593221611275,
        "roa_avg2y": -0.583424299979922,
        "roa_period_end": -0.5283162001809796,
        "roe_avg2y": -0.6481966155974306,
        "roe_period_end": -0.5930222193030195
      }
    },
    {
      "accn": "0001764013-26-000064",
      "filed": "2026-05-20",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 759000.0,
        "cash": 713971000.0,
        "eps_diluted": -2.73,
        "free_cash_flow": -376633000.0,
        "net_income": -413840000.0,
        "operating_cash_flow": -375874000.0,
        "stockholders_equity": 707447000.0,
        "total_assets": 776222000.0,
        "total_liabilities": 68775000.0
      },
      "period_end": "2025-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09721576315964306,
        "roa_avg2y": -0.573747025309392,
        "roa_period_end": -0.5331464452179917,
        "roe_avg2y": -0.6245679910413793,
        "roe_period_end": -0.5849766837657097
      }
    },
    {
      "accn": "0001764013-26-000064",
      "filed": "2026-05-20",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 360000.0,
        "cash": 635365000.0,
        "eps_diluted": -1.88,
        "free_cash_flow": -214587000.0,
        "net_income": -259336000.0,
        "operating_cash_flow": -214227000.0,
        "stockholders_equity": 617757000.0,
        "total_assets": 666365000.0,
        "total_liabilities": 48608000.0
      },
      "period_end": "2024-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.0786846607970448,
        "roa_avg2y": -0.48374421634709097,
        "roa_period_end": -0.38918010399705866,
        "roe_avg2y": -0.5291216229312696,
        "roe_period_end": -0.41980260846902584
      }
    },
    {
      "accn": "0001764013-26-000064",
      "filed": "2026-05-20",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 197000.0,
        "cash": 376532000.0,
        "eps_diluted": -1.71,
        "free_cash_flow": -188390000.0,
        "net_income": -210960000.0,
        "operating_cash_flow": -188193000.0,
        "stockholders_equity": 362494000.0,
        "total_assets": 405838000.0,
        "total_liabilities": 43344000.0
      },
      "period_end": "2023-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.11957163428911927,
        "roa_avg2y": -0.4579108792904726,
        "roa_period_end": -0.5198133245285065,
        "roe_avg2y": -0.5069210242707424,
        "roe_period_end": -0.5819682532676403
      }
    },
    {
      "accn": "0001764013-25-000092",
      "filed": "2025-05-29",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 254000.0,
        "cash": 493817000.0,
        "eps_diluted": -1.43,
        "free_cash_flow": -106366000.0,
        "net_income": -156730000.0,
        "operating_cash_flow": -106112000.0,
        "stockholders_equity": 469825000.0,
        "total_assets": 515564000.0,
        "total_liabilities": 45739000.0
      },
      "period_end": "2022-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09735326983451285,
        "roa_avg2y": -0.33776088219099554,
        "roa_period_end": -0.30399717590832565,
        "roe_avg2y": -0.3639361201897121,
        "roe_period_end": -0.33359229500345866
      }
    },
    {
      "accn": "0001764013-23-000065",
      "filed": "2023-05-22",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 210000.0,
        "cash": 400146000.0,
        "eps_diluted": -1.22,
        "free_cash_flow": -83537000.0,
        "net_income": -107431000.0,
        "operating_cash_flow": -83327000.0,
        "stockholders_equity": 391480000.0,
        "total_assets": 412489000.0,
        "total_liabilities": 21009000.0
      },
      "period_end": "2021-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.05366557678553183,
        "roa_avg2y": -0.41171082785949153,
        "roa_period_end": -0.2604457330983372,
        "roe_avg2y": -0.4425135259263226,
        "roe_period_end": -0.2744227035863901
      }
    },
    {
      "accn": "0001764013-22-000059",
      "filed": "2022-06-08",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 31000.0,
        "cash": 100571000.0,
        "free_cash_flow": -53388000.0,
        "net_income": -66388000.0,
        "operating_cash_flow": -53357000.0,
        "stockholders_equity": 94069000.0,
        "total_assets": 109387000.0,
        "total_liabilities": 15318000.0
      },
      "period_end": "2020-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.16283791684827095,
        "roa_avg2y": -1.0775960719068296,
        "roa_period_end": -0.6069094133672192,
        "roe_avg2y": -1.3093247081098138,
        "roe_period_end": -0.7057372779555433
      }
    },
    {
      "accn": "0001764013-21-000052",
      "filed": "2021-06-01",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 52000.0,
        "cash": 6985000.0,
        "free_cash_flow": -28599000.0,
        "net_income": -28599000.0,
        "operating_cash_flow": -28547000.0,
        "stockholders_equity": 7339000.0,
        "total_assets": 13828000.0,
        "total_liabilities": 6489000.0
      },
      "period_end": "2019-03-31",
      "ratio_units": {
        "leverage": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.8841804060498706,
        "roe_avg2y": -8.256062355658198,
        "roe_period_end": -3.896852432211473
      }
    },
    {
      "accn": "0000950123-20-006444",
      "filed": "2020-06-29",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -411000.0
      },
      "period_end": "2018-07-06",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001764013-26-000064",
    "filed": "2026-05-20",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001764013.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001764013.json"
  },
  "ticker": "IMVT"
}